comparemela.com

Latest Breaking News On - Vanda pharmaceuticals inc - Page 4 : comparemela.com

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
Kevin-moran
Jack-kelleher-dan-moore
Prnewswire-vanda-pharmaceuticals-inc
Vanda-pharmaceuticals-inc
Conference-call
Vice-president
Chief-financial-officer
Jack-kelleher

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024

/PRNewswire/ Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2024 on Wednesday, May 8, 2024,.

Washington
United-states
Kevin-moran
Jack-kelleher-dan-moore
Vanda-pharmaceuticals-inc
Prnewswire-vanda-pharmaceuticals-inc
Conference-call
Vice-president
Chief-financial-officer
Jack-kelleher

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a drop of 16.9% from the March 31st total of 2,490,000 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover […]

Los-angeles
California
United-states
Vanda-pharmaceuticals-inc
Jacobs-levy-equity-management-inc
Nasdaq
Stonepine-capital-management
Capital-partners
Acadian-asset-management
Vanda-pharmaceuticals-company-profile
News-ratings-for-vanda-pharmaceuticals-daily

Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded by StockNews.com to Hold

StockNews.com downgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) from a buy rating to a hold rating in a report issued on Monday. Separately, TheStreet lowered Vanda Pharmaceuticals from a c- rating to a d rating in a research note on Thursday, February 8th. View Our Latest Analysis on VNDA Vanda Pharmaceuticals Price Performance […]

China
New-york
United-states
Switzerland
Swiss
Nasdaq
Vanda-pharmaceuticals-price-performance
News-ratings-for-vanda-pharmaceuticals-daily
Institutional-investors-weigh-in-on-vanda-pharmaceuticals
China-universal-asset-management-co
Vanda-pharmaceuticals-inc

Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Hold at StockNews.com

Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Hold at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Capital-partners
Vanda-pharmaceuticals-inc
Nasdaq
Vanda-pharmaceuticals-price-performance
News-ratings-for-vanda-pharmaceuticals-daily
Stonepine-capital-management
Vanda-pharmaceuticals-company-profile
Acadian-asset-management
Exchange-traded-concepts
Vanda-pharmaceuticals
Institutional-trading-of-vanda-pharmaceuticals
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.